SJP002

· Samjin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SJP002, covering 2022-04-07 to 2022-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome. [Phase 2]

See pricing